Summary
A prospective study of lymphocyte subsets has been carried out for 18 months in 58 healthy first-degree relatives of Type 1 (insulin-dependent) probands. Subjects selected for presence or absence of islet cell antibodies included 10 with complement-fixing islet cell antibodies, 10 with conventional islet cell antibodies and 38 without islet cell antibodies. Immunoregulatory and effector lymphocyte subsets, and in particular activated T-cells, were investigated using a panel of monoclonal antibodies. The results showed no significant changes in total T, helper, suppressor/cytotoxic cells or K/ NK cells. Activated T-cells were observed at least once in 22 subjects using the 4F2 monoclonal antibody and in 11 using the Tac antibody. Seven subjects had 4F2-positive cells on repeated occasions and one twice showed Tac-positive cells. Fluctuations and/or loss of islet cell antibodies were observed during follow-up. There was no correlation between presence of activated T-cells and either islet cell antibody status or HLA haplotype sharing with the diabetic proband. On the other hand, a significant correlation was observed between HLA-DR3 positivity of subjects and the occurrence of activated T-cells (both 4F2-positive and Tac-positive). We conclude that subjects with HLA-DR3 may be especially prone to T-cell activation. As none of the ‘high risk’ individuals developed diabetes in the course of follow-up, the relevance of these observations in the pathogenesis of Type 1 diabetes needs more prolonged investigation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jackson RA, Morris MA, Haynes BF, Eisenbarth GS (1982) Increased circulating Ia bearing T cells in Type 1 diabetes mellitus. N Engl J Med 306: 785–788
Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Spencer KM, Bottazzo GF, Beverley PCL, Kyner JL, Cudworth AG (1983) Monoclonal antibodies defined abnormalities of T lymphocytes in Type 1 diabetes. Diabetes 32: 91–94
Buschard K, Madsbad S, Rygaard J (1980) Depressed suppressor cell activity in patients with newly diagnosed insulin dependent diabetes mellitus. Clin Exp Immunol 45: 25–31
Fairchild RS, Kyner JL, Abdou NI (1982) Specific immunoregulation abnormality in insulin dependent diabetes mellitus. J Lab Clin Med 99: 175–186
Pozzilli P, Sensi M, Gorsuch AN, Bottazzo GF, Cudworth AG (1979) Evidence for raised K cell levels in Type 1 diabetes. Lancet 2: 173–175
Sensi M, Pozzilli P, Gorsuch AN, Bottazzo GF, Cudworth AG (1981) Increased killer cell activity in Type 1 diabetes. Diabetologia 20: 106–109
Bottazzo GF, Pozzilli P, Mirakian R, Dean BM, Doniach D (1984) Early immunological events in diabetes. In: Andreani D, Di Mario U, Federlin KF, Heding LG (eds) Immunology in diabetes. Kimptom Medical Publications, London, pp95–104
Cudworth AG, Wolf E (1982) The genetic susceptibility to Type 1 diabetes. Clin Endocrinol Metab 11: 389–406
Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224–230
Beverley PCL, Callard RE (1981) Distinctive functional characteristics of lymphocytes defined by E-rosetting or a monoclonal antibody anti-T cell antibody. Eur J Immunol 11: 329–334
Beverley PCL (1982) The application of monoclonal antibodies to the study of lymphoreticular cells. Proc Roy Soc Edinburgh 13: 521–527
Bay Y, Callard RE, Beverley PCL, Bodmer WF (1983) Two monoclonal antibodies (H25 and H366) defined cells with K/NK activity. Eur J Immunol 48: 189–195
Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer JH, Mostowski HS, Thomas CA, Strominger JL, Fauci AS (1980) Characterisation of a monoclonal antibody (4F2) which binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126: 1409–1411
Leonard JJM, Depper T, Uchiyama T, Smith KA, Waldmann TA, Greene C (1982) A monoclonal antibody that appears to recognize the receptor for human T cell growth factor: partial characterization of the receptor. Nature (Lond) 300: 267–269
Sensi M, Pozzilli P, Di Mario U (1984) A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates. J Clin Lab Immunol 13:101–102
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement fixing islet cell antibodies in Type 1 diabetes: possible monitors of active beta cell damage. Lancet 1: 668–672
Bodmer WF (1980) The HLA system and disease. J Roy Coll Physicians 14: 43–50
Bodmer WF (1981) MHC gene clusters of man and mouse. In: Russell E (ed) Mammalian genetics and cancer, Alan Liss, New York, pp 213–240
Bottazzo GF, Pujol Borrell R, Hanafusa T (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2: 1115–1118
Lawley TJR, Hall A, Fauci AS, Katz SI, Hamburger MI, Frank MM (1981) Defective Fc receptor functions associated with the HLA-B8/DRW3 haplotype. N Engl J Med 304: 185–187
Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF (1984) Family studies in Type 1 diabetes: evidence of fluctuating islet cell autoimmunity in unaffected relatives. Lancet 1: 764–765
Lamb JR, Feldmann M (1982) A human suppressor T cell clone which recognizes an autologous helper T cell clone. Nature 300: 456–458
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pozzilli, P., Sensi, M., Al-Sakkaf, L. et al. Prospective study of lymphocyte subsets in subjects genetically susceptible to Type 1 (insulin-dependent) diabetes. Diabetologia 27 (Suppl 1), 132–135 (1984). https://doi.org/10.1007/BF00275670
Issue Date:
DOI: https://doi.org/10.1007/BF00275670